Search research articles
Contact Us
Filters
Showing results (71-80 of 78) with videos related to
Page
of 8
Sort By:
You have reached the last page of results.
This site can display upto 78 results.
JAMA
|
March 13, 2014
Prevalence, characteristics, and publication of discontinued randomized trials
Benjamin Kasenda, Erik von Elm, John You, et al.
Plos Medicine
|
June 29, 2016
Agreements between Industry and Academia on Publication Rights: A Retrospective Study of Protocols and Publications of Randomized Clinical Trials
Benjamin Kasenda, Erik von Elm, John J You, et al.
The Journal of Pediatrics
|
April 15, 2017
Premature Discontinuation of Pediatric Randomized Controlled Trials: A Retrospective Cohort Study
Stefan Schandelmaier, Yuki Tomonaga, Dirk Bassler, et al.
Critical Care Medicine
|
October 16, 2015
Premature Discontinuation of Randomized Trials in Critical and Emergency Care: A Retrospective Cohort Study
Stefan Schandelmaier, Erik von Elm, John J You, et al.
JAMA Oncology
|
April 7, 2017
Clinical Characterization of the Pheochromocytoma and Paraganglioma Susceptibility Genes SDHA, TMEM127, MAX, and SDHAF2 for Gene-Informed Prevention
Birke Bausch, Francesca Schiavi, Ying Ni, et al.
Annals of Surgery
|
July 1, 2014
Completion and Publication Rates of Randomized Controlled Trials in Surgery: An Empirical Study
Rachel Rosenthal, Benjamin Kasenda, Salome Dell-Kuster, et al.
Human Mutation
|
October 28, 2010
Risk profiles and penetrance estimations in multiple endocrine neoplasia type 2A caused by germline RET mutations located in exon 10
Karin Frank-Raue, Lisa A Rybicki, Zoran Erlic, et al.
Cancer Research
|
April 9, 2009
Clinical predictors for germline mutations in head and neck paraganglioma patients: cost reduction strategy in genetic diagnostic process as fall-out
Hartmut P H Neumann, Zoran Erlic, Carsten C Boedeker, et al.
Page
of 8
Search research articles
Search
Showing results (71-80 of 78) with videos related to
Sort By:
Page
of 8
You have reached the last page of results.
This site can display upto 78 results.
JAMA
|
March 13, 2014
Prevalence, characteristics, and publication of discontinued randomized trials
Benjamin Kasenda, Erik von Elm, John You, et al.
Plos Medicine
|
June 29, 2016
Agreements between Industry and Academia on Publication Rights: A Retrospective Study of Protocols and Publications of Randomized Clinical Trials
Benjamin Kasenda, Erik von Elm, John J You, et al.
The Journal of Pediatrics
|
April 15, 2017
Premature Discontinuation of Pediatric Randomized Controlled Trials: A Retrospective Cohort Study
Stefan Schandelmaier, Yuki Tomonaga, Dirk Bassler, et al.
Critical Care Medicine
|
October 16, 2015
Premature Discontinuation of Randomized Trials in Critical and Emergency Care: A Retrospective Cohort Study
Stefan Schandelmaier, Erik von Elm, John J You, et al.
JAMA Oncology
|
April 7, 2017
Clinical Characterization of the Pheochromocytoma and Paraganglioma Susceptibility Genes SDHA, TMEM127, MAX, and SDHAF2 for Gene-Informed Prevention
Birke Bausch, Francesca Schiavi, Ying Ni, et al.
Annals of Surgery
|
July 1, 2014
Completion and Publication Rates of Randomized Controlled Trials in Surgery: An Empirical Study
Rachel Rosenthal, Benjamin Kasenda, Salome Dell-Kuster, et al.
Human Mutation
|
October 28, 2010
Risk profiles and penetrance estimations in multiple endocrine neoplasia type 2A caused by germline RET mutations located in exon 10
Karin Frank-Raue, Lisa A Rybicki, Zoran Erlic, et al.
Cancer Research
|
April 9, 2009
Clinical predictors for germline mutations in head and neck paraganglioma patients: cost reduction strategy in genetic diagnostic process as fall-out
Hartmut P H Neumann, Zoran Erlic, Carsten C Boedeker, et al.
Page
of 8